Improving the process of therapeutic development
Harvard, MIT, and the FDA have partnered to create a center focused on innovative approaches for the development and evaluation of medical products. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments. Click below to learn more.
What is Regulatory Science?
Regulatory Science develops theory and methods to improve the complex process of drug and device development from discovery through post-market evaluation. This includes all aspects of the interlinked procedures used to invent a new drug or device, test it in clinical trials, and get it into the hands of patients and physicians.